TSPO and Alzheimer disease: A chronic inflammatory role in AD is supported by the elevation of inflammatory biomarkers in blood and cerebrospinal fluid (CSF) studies, as well as by positron emission tomography (PET) imaging with translocator protein (TSPO) ligands, which detect microglial activation in vivo.